Product
Transcatheter Arterial Chemoembolization
1 clinical trial
1 indication
Indication
Stomach CancerClinical trial
A Phase II Study of Neoadjuvant Transcatheter Arterial Chemoembolization（TACE）Plus PD-1 Antibody (Tislelizumab) in the Locally Advanced Stomach AdenocarcinomaStatus: Recruiting, Estimated PCD: 2024-12-01